Peptidomimetics are compounds that mimic the structure and/or function of peptides, which are short chains of amino acids that can have various biological activities in the body. Peptidomimetics are designed to be more stable and have improved pharmacokinetic properties compared to natural peptides, making them attractive candidates for drug development. These compounds can target specific protein-protein interactions, enzyme activities, or receptor binding sites, and have been explored for a wide range of therapeutic applications, including cancer, infectious diseases, and neurological disorders. Peptidomimetics have the potential to overcome limitations of natural peptides, such as poor oral bioavailability and rapid degradation, and are a promising area of research in the development of new drug candidates.